Fundamental dimension Equity attribute | ENCTFPeer $0.03830.00% Cap $1.08MP/E -0.6x QuantScore20/100 | BKSLFLeader $0.000.00% Cap $596P/E -0.0x QuantScore50/100 | CCOBPeer $0.0001▼-0.00% Cap $10.44KP/E -0.0x QuantScore18/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
50/100 |
64/100 |
53/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 21/100 | 20/100 |
Growth Revenue / earnings growth & margins | 12/100 | 50/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.6x | -0.0x | -0.0x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -132.6x | -3.3x | -1.1x |
Price / Sales | — | 0.0x | — |
Price / Free Cash Flow | -28.6x | -0.0x | -0.0x |
PEG ratio | -0.08 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | -1772.29 (Distress) | -1.56 (Distress) | -1686.78 (Distress) |
Total debt / equity | -0.61 | 0.34 | -0.62 |
Quick ratio | 0.0x | 0.1x | 0.0x |
Interest coverage | -0.1x | -24.1x | -6.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +4.3% | +53.8% | -53.2% |
Gross margin (TTM) | 0.0% | -25.7% | 0.0% |
Operating margin (FY) | — | -57.1% | — |
FCF margin (FY) | — | -480.5% | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | 0.0% |
3M return | +12666.7% | 0.0% | 0.0% |
6M return | +104.3% | 0.0% | 0.0% |
Year to date | +46.8% | 0.0% | 0.0% |
1Y return | +65.6% | 0.0% | 0.0% |
3Y return | +83.2% | 0.0% | -85.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.8006 -2190.4% premium | $2.33 +23308485.2% upside | $-0.0122 -12290.0% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |